1 |
GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019: a systematic analysis for the global burden of disease study 2019 [J]. Lancet,2020,396(10258):1204-1222.
|
2 |
Kornblith LZ,Moore HB,Cohen MJ.Trauma-induced coagulopathy:The past,present,and future[J].J Thromb Haemost,2019,17(6):852-862.
|
3 |
Sheppard FR,Schaub LJ,Cap AP,et al.Whole blood mitigates the acute coagulopathy of trauma and avoids the coagulopathy of crystalloid resuscitation[J].J Trauma Acute Care Surg,2018,85(6):1055-1062
|
4 |
Pierce RW,Shabanova V,Canarie M,et al.Angiopoietin level trajectories in toddlers with severe sepsis and septic shock and their effect on capillary endothelium[J].Shock,2019,51(3):298-305.
|
5 |
Borges JP,Nascimento AR,Lopes GO,et al.The impact of exercise frequency upon microvascular endothelium function and oxidative stress among patients with coronary artery disease[J].Clin Physiol Funct Imaging,2018,38(5):840-846.
|
6 |
Harel F,Langleben D,Provencher S,et al.Molecular imaging of the human pulmonary vascular endothelium in pulmonary hypertension:a phase II safety and proof of principle trial[J].Eur J Nucl Med Mol Imaging,2017,44(7):1136-44.
|
7 |
杨映波,王正国,朱佩芳,等. 创伤病人循环内皮细胞体外培养的研究[J]. 中华创伤杂志,1993,9(6):317-319.
|
8 |
Hahn RG,Patel V,Dull RO.Human glycocalyx shedding:systematic review and critical appraisal[J].Acta Anaesthesiol Scand,2021,65(5):590-606.
|
9 |
尹文,冯筑生. 系统性内皮病在创伤性休克领域研究[J]. 创伤外科杂志,2021,23(11):801-804.
|
10 |
Cardenas JC,Dong JF,Kozar RA.Injury-induced endotheliopathy:what you need to know [J].J Trauma Acute Care Surg,2023,95(4):454-463.
|
11 |
Patterson EK,Cepinskas G,Fraser DD.Endothelial glycocalyx degradation in critical illness and injury[J].Front Med(Lausanne),2022(9):898592.
|
12 |
Moore KH,Murphy HA,George EM. The glycocalyx: a central regulator of vascular function[J].Am J Physiol Regul Integr Comp Physiol,2021,320(4):R508-R518.
|
13 |
Wang G,Kostidis S,Tiemeier GL,et al. Shear stress regulation of endothelial glycocalyx structure is determined by glucobiosynthesis[J].Arterioscler Thromb Vasc Biol,2020,40(2):350-364.
|
14 |
Gonzalez Rodriguez E,Ostrowski SR,Cardenas JC,et al.Syndecan-1:a quantitative marker for the endotheliopathy of trauma[J].J Am Coll Surg,2017,225(3):419-427.
|
15 |
Plug T,Meijers JC.Structure-function relationships in thrombin-activatable fibrinolysis inhibitor[J].J Thromb Haemost,2016,14(4):633-644.
|
16 |
Bouma BN,Marx PF,Mosnier LO,et al.Thrombin-activatable fibrinolysis inhibitor(TAFI,plasma procarboxypeptidase b,procarboxypeptidase r,procarboxypeptidase u)[J].Thromb Res,2001,101(5):329-354.
|
17 |
Brohi K,Cohen MJ,Ganter MT,et al.Acute traumatic coagulopathy:initiated by hypoperfusion:modulated through the protein c pathway?[J].Ann Surg,2007,245(5):812-818.
|
18 |
Knipe L,Meli A,Hewlett L,et al.A revised model for the secretion of tPA and cytokines from cultured endothelial cells[J].Blood,2010,116(12):2183-2191.
|
19 |
Hayakawa M,Tsuchida T,Honma Y,et al.Fibrinolytic system activation immediately following trauma was quickly and intensely suppressed in a rat model of severe blunt trauma[J].Sci Rep,2021,11(1):20283.
|
20 |
Chapman MP,Moore EE,Moore HB,et al.Overwhelming tPA release,not PAI-1 degradation,is responsible for hyperfibrinolysis in severely injured trauma patients[J].J Trauma Acute Care Surg,2016,80(1):16-23.
|
21 |
Gall LS,Vulliamy P,Gillespie S,et al.The S100A10 pathway mediates an occult hyperfibrinolytic subtype in trauma patients[J].Ann Surg,2019,269(6):1184-1191.
|
22 |
Sang Y,Roest M,de Laat B,et al.Interplay between platelets and coagulation[J].Blood Rev,2021(46):100733.
|
23 |
Neubauer K,Zieger B.Endothelial cells and coagulation[J].Cell Tissue Res,2022,387(3):391-398.
|
24 |
Gkaliagkousi E,Ritter J,Ferro A.Platelet-derived nitric oxide signaling and regulation[J].Circ Res,2007,101(7):654-662.
|
25 |
Johansson PI,Stensballe J,Ostrowski SR.Shock induced endotheliopathy(SHINE)in acute critical illness-a unifying pathophysiologic mechanism[J].Crit Care,2017,21(1):25.
|
26 |
Johansson PI,Eriksen CF,Schmal H,et al.Efficacy and safety of iloprost in trauma patients with haemorrhagic shock-induced endotheliopathy-Protocol for the multicentre randomized,placebo-controlled,blinded,investigator-initiated shine-trauma trial[J].Acta Anaesthesiol Scand,2021,65(4):551-557.
|
27 |
Henriksen HH,Marín de Mas I,Nielsen LK,et al.Endothelial cell phenotypes demonstrate different metabolic patterns and predict mortality in trauma patients[J].Int J Mol Sci,2023,24(3):2257.
|
28 |
Johansson PI,Henriksen HH,Stensballe J,et al.Traumatic endotheliopathy:a prospective observational study of 424 severely injured patients[J].Annals of surgery,2017,265(3):597-603.
|
29 |
Chesebro BB,Rahn P,Carles M,et al.Increase in activated protein C mediates acute traumatic coagulopathy in mice[J].Shock,2009,32(6):659-665.
|
30 |
Wallen TE,Singer KE,Elson NC,et al.Defining endotheliopathy in murine polytrauma models[J].Shock,2022,57(6):291-298.
|
31 |
Barrett L,Curry N,Abu-Hanna J.Experimental models of traumatic injuries:do they capture the coagulopathy and underlying endotheliopathy induced by human trauma?[J].Int J Mol Sci,2023,24(13):11174.
|
32 |
Bunch CM,Chang E,Moore EE,et al.SHock-INduced Endotheliopathy(SHINE):a mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shock[J].Front Physiol,2023(14):1094845.
|
33 |
Yang Z,Le TD,Simovic MO,et al.Traumatized triad of complementopathy,endotheliopathy,and coagulopathy-Impact on clinical outcomes in severe polytrauma patients[J].Front Immunol,2022(13):991048.
|
34 |
Keyloun JW,Le TD,Orfeo T,et al.Assessing factor v antigen and degradation products in burn and trauma patients[J].J Surg Res,2022(274):169-177.
|
35 |
Johansson PI,Stensballe J,Rasmussen LS,et al.High circulating adrenaline levels at admission predict increased mortality after trauma[J].J Trauma Acute Care Surg,2012,72(2):428-436.
|
36 |
Ostrowski SR,Johansson PI.Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy [J].J Trauma Acute Care Surg,2012,73(1):60-66.
|
37 |
Johansen ME,Johansson PI,Ostrowski SR,et al.Profound endothelial damage predicts impending organ failure and death in sepsis[J].Semin Thromb Hemost,2015,41(1):16-25.
|
38 |
Johansson PI,Sørensen AM,Perner A,et al.Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline,platelets,and leukocytes in response to increasing injury severity[J].Crit Care Med,2012,40(6):1844-1850.
|
39 |
Fröhlich M,Lefering R,Probst C,et al.Epidemiology and risk factors of multiple-organ failure after multiple trauma:an analysis of 31,154 patients from the TraumaRegister DGU[J].J Trauma Acute Care Surg,2014,76(4):921-927.
|
40 |
Krocker JD,Lee KH,Henriksen HH,et al.Exploratory investigation of theplasma proteome associated with the endotheliopathy of trauma[J].Int J Mol Sci,2022,23(11):6213.
|
41 |
Wang S,Song R,Wang Z,et al.S100A8/A9 in inflammation[J].Front Immunol,2018(9):1298.
|
42 |
Staedtke V,Bai RY,Kim K,et al.Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome[J].Nature,2018,564(7735):273-277.
|
43 |
Thul PJ,Åkesson L,Wiking M,et al.A subcellular map of the human proteome[J].Science,2017,356(6340):eaal3321.
|
44 |
Erukhimov JA,Tang ZL,Johnson BA,et al.Actin-containing sera from patients with adult respiratory distress syndrome are toxic to sheep pulmonary endothelial cells[J].Am J Respir Crit Care Med,2000,162(1):288-294.
|
45 |
Haywood-Watson RJ,Holcomb JB,Gonzalez EA,et al.Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation[J].PloS one,2011,6(8):e23530.
|
46 |
Johansson PI,Stensballe J,Oliveri R,et al.How i treat patients with massive hemorrhage[J].Blood,2014,124(20):3052-3058.
|
47 |
Lopez E,Peng Z,Kozar RA,et al.Antithrombin III contributes to the protective effects of fresh frozen plasma following hemorrhagic shock by preventing syndecan-1 shedding and endothelial barrier disruption[J].Shock,2020,53(2):156-163.
|
48 |
Deng X,Cao Y,Huby MP,et al.Adiponectin in fresh frozen plasma contributes to restoration of vascular barrier function after hemorrhagic shock[J].Shock,2016,45(1):50-54.
|
49 |
Bruggeman LA,Pellicoro JA,Horigan EA,et al.Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression[J].Kidney Int,1993,43(6):1219-1225.
|
50 |
Sussmann M,Sarbia M,Meyer-Kirchrath J,et al.Induction of hyaluronic acid synthase 2(HAS2)in human vascular smooth muscle cells by vasodilatory prostaglandins[J].Circ Res,2004,94(5):592-600.
|
51 |
Kawabe J,Yuhki K,Okada M,et al.Prostaglandin I2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling[J].Arterioscler Thromb Vasc Biol,2010,30(3):464-470.
|
52 |
Birukova AA,Tian Y,Dubrovskyi O,et al.VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost[J].J Cell Physiol,2012,227(10):3405-3416.
|
53 |
Joffre J,Hellman J,Ince C,et al.Endothelial responses in sepsis[J].Am J Respir Crit Care Med,2020,202(3):361-370.
|
54 |
Gao W,Fang F,Xia TJ,et al.Doxycycline can reduce glycocalyx shedding by inhibiting matrix metalloproteinases in patients undergoing cardiopulmonary bypass: a randomized controlled trial[J].Microvasc Res,2022(142):104381.
|
55 |
Vidaurre M,Osborn BK,Lowak KD,et al.A 3-O-sulfated heparan sulfate dodecasaccharide(12-mer)suppresses thromboinflammation and attenuates early organ injury following trauma and hemorrhagic shock[J].Front Immunol,2023(14):1158457.
|
56 |
Anderson TNHinson HE,Dewey EN,et al.Early tranexamic acid administration after traumatic brain injury is associated with reduced syndecan-1 and angiopoietin-2 in patients with traumatic intracranial hemorrhage[J].J Head Trauma Rehabil,2020,35(5):317-323.
|
57 |
Thielen O,Mitra S,Debot M,et al.Mitigation of trauma induced endotheliopathy by activated protein c: a potential therapeutic for post-injury thromboinflammation[EB/OL].(2023-09-21)[2023-09-30].
URL
|